"10.1371_journal.pone.0055784","plos one","2013-02-07T00:00:00Z","Julian I Borissoff; Jeroen J T Otten; Sylvia Heeneman; Peter Leenders; René van Oerle; Oliver Soehnlein; Sarah T B G Loubele; Karly Hamulyák; Tilman M Hackeng; Mat J A P Daemen; Jay L Degen; Hartmut Weiler; Charles T Esmon; Joanne van Ryn; Erik A L Biessen; Henri M H Spronk; Hugo ten Cate","Laboratory for Clinical Thrombosis and Hemostasis, Department of Internal Medicine, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, The Netherlands; Program in Cellular and Molecular Medicine, Boston Childrens Hospital, Harvard Medical School, Boston, Massachusetts, United States of America; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States of America; Department of Pathology, Experimental Vascular Pathology Research Group, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands; Institute for Cardiovascular Molecular Research, Medical Faculty, RWTH Aachen University, Aachen, Germany; Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, The Netherlands; Developmental Biology, Childrens Hospital Research Foundation, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America; Blood Research Institute, The Blood Center of Southeastern Wisconsin, Milwaukee, United States of America; Oklahoma Medical Research Foundation and Howard Hughes Medical Institute, Oklahoma City, Oklahoma, United States of America; Department of CardioMetabolic Disease Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany","Conceived and designed the experiments: JIB EALB SH MJAPD HMS HtC. Performed the experiments: JIB JJTO PL RvO OS STBGL. Analyzed the data: JIB JJTO PL RvO OS STBGL HMS HtC. Contributed reagents/materials/analysis tools: KH TMH MJAPD JLD HW CTE JvR. Wrote the paper: JIB HMS HtC.","The authors have the following interests. Boehringer Ingelheim GmbH provided Dabigatran etexilate-supplemented and placebo diets for this study and is the employer of Joanne van Ryn. Dr. ten Cate has received speaker fees from Bayer, Boehringer Ingelheim, GlaxoSmithKline and Leo Pharma. There are no further patents, products in development or marketed products to declare. This does not alter the authors‚ adherence to all the PLOS ONE policies on sharing data and materials.","2013","02","Julian I Borissoff","JIB",17,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
